ARCHIVES

ASCO’s Lichter Says. Dingell, Stupak Urge FDA To “Act With Due Haste To Avoid Endangering Patients” Steered To ESAs.

This article is from The Cancer Letter archive.

Vol. 34 No. 09 | March 7, 2008

Download PDF Visit The Full Archive

Related Articles

Abrams, Tomaszewski To Co-Direct DCTD

June 10, 2011

Also in this 8-page issue: Amgen names PhRMA executive Rodger Currie vice president for government affairs.

April 30, 2004

DCT Announces Neutron Therapy RFP Available

January 19, 1979

NCI, Advisers Lean To Smaller Increases For R01a, Philosophy Of Spreading Money Among More Grants

January 15, 1982

Leukemia Society Program In Transitional Research.

January 14, 2000

Blinatumomab Demonstrates High Response Rate in ALL

June 29, 2012